Changing Services, Changing Oncology Pharmacy COVID-19 Position Statement

During the COVID-19 pandemic, oncology pharmacy services have had to adapt quickly and innovatively to continue to provide care to cancer patients. This document outlines both the clinical and operational responses implemented by BOPA members during the initial phase of COVID-19.

For clinical services we summarise different examples of responses , the key role oncology pharmacy services play in this response and recommendations for continued oncology pharmacy involvement in the future.
For operational services we identify the benefits, opportunities, risks and challenges of the responses and further considerations for reviewing these responses.

The document also highlights some of the next steps oncology pharmacy services and the wider oncology service could take in planning for the future phase of the COVID-19 pandemic.

We hope BOPA members find this document useful as it shows how we in oncology pharmacy have a pivotal role in providing cancer care and that whatever the challenges of continuing to provide care in a post COVID-19 world, so long as we plan for the risks, take opportunities, prepare to adapt and share our learning as a community, we will be able to meet them.

To access the document you must be a free or paid member of BOPA.
https://www.bopa.org.uk/resources/changing-services-changing-oncology-pharmacy-covid-19-position-statement/